A detailed history of Apg Asset Management N.V. transactions in Pfizer Inc stock. As of the latest transaction made, Apg Asset Management N.V. holds 6,361,710 shares of PFE stock, worth $178 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
6,361,710
Previous 6,226,238 2.18%
Holding current value
$178 Million
Previous $179 Million 1.52%
% of portfolio
0.29%
Previous 0.32%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $3.51 Million - $4.03 Million
135,472 Added 2.18%
6,361,710 $177 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $6.45 Million - $8.37 Million
246,680 Added 4.13%
6,226,238 $179 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $28.9 Million - $33.8 Million
-900,960 Reduced 13.09%
5,979,558 $198 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $575,355 - $665,672
15,929 Added 0.23%
6,880,518 $252 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $25.6 Million - $33.4 Million
-651,121 Reduced 8.66%
6,864,589 $280 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $198 Million - $258 Million
4,734,869 Added 170.27%
7,515,710 $385 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $20 Million - $24.4 Million
-456,751 Reduced 14.11%
2,780,841 $124 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $7.91 Million - $9.38 Million
-170,024 Reduced 4.99%
3,237,592 $162 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $21.2 Million - $26.3 Million
-463,976 Reduced 11.98%
3,407,616 $159 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $3.26 Million - $4.83 Million
78,804 Added 2.08%
3,871,592 $201 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $6.97 Million - $8.95 Million
-177,588 Reduced 4.47%
3,792,788 $141 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $6.26 Million - $7.09 Million
-174,334 Reduced 4.21%
3,970,376 $131 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $79.7 Million - $89.8 Million
-2,378,373 Reduced 36.46%
4,144,710 $128 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $30.6 Million - $38.9 Million
-914,712 Reduced 12.3%
6,523,083 $196 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $5.15 Million - $6.04 Million
162,051 Added 2.23%
7,437,795 $233 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $9.64 Million - $11.7 Million
319,915 Added 4.6%
7,275,744 $212 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $178 Million - $255 Million
-6,600,551 Reduced 48.69%
6,955,829 $227 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $284 Million - $406 Million
10,524,792 Added 347.17%
13,556,380 $513 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $4.17 Million - $4.73 Million
126,704 Added 4.36%
3,031,588 $106 Million
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $325 Million - $421 Million
-9,993,796 Reduced 77.48%
2,904,884 $95.7 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $24.3 Million - $27.3 Million
-657,700 Reduced 4.85%
12,898,680 $491 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $105 Million - $116 Million
-2,804,000 Reduced 17.14%
13,556,380 $513 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $8.78 Million - $10 Million
228,300 Added 1.42%
16,360,380 $625 Million
Q3 2018

Nov 09, 2018

BUY
$34.47 - $41.81 $38.7 Million - $46.9 Million
1,122,000 Added 7.47%
16,132,080 $612 Million
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $46.4 Million - $49.5 Million
1,406,900 Added 10.34%
15,010,080 $466 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $66.1 Million - $76.6 Million
2,070,000 Added 17.95%
13,603,180 $393 Million
Q4 2017

Jan 24, 2018

SELL
$33.26 - $35.29 $4.28 Million - $4.54 Million
-128,560 Reduced 1.1%
11,533,180 $348 Million
Q3 2017

Oct 19, 2017

BUY
$31.0 - $34.15 $362 Million - $398 Million
11,661,740
11,661,740 $416 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.